Seek Returns

LLY vs. NVDA: Eli Lilly vs. NVIDIA Stock Comparison

How do Eli Lilly (LLY) and NVIDIA (NVDA) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas NVIDIA (NVDA) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.

Company profile comparison for Eli Lilly (LLY) and NVIDIA (NVDA)
Profile ItemLLYNVDA
NameEli Lilly and CompanyNVIDIA Corporation
Country/RegionUnited StatesUnited States
GICS SectorHealth CareInformation Technology
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesSemiconductors & Semiconductor Equipment
GICS IndustryPharmaceuticalsSemiconductors & Semiconductor Equipment
GICS Sub-IndustryPharmaceuticalsSemiconductors
Market Capitalization1,206.07 billion USD4,506.80 billion USD
CurrencyUSDUSD
ExchangeNYSENasdaq
Listing DateJune 1, 1972January 22, 1999
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

LLY
NVDA
GSPC
Loading price history…
Eli Lilly (LLY) vs. NVIDIA (NVDA), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Eli Lilly (LLY) and NVIDIA (NVDA). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Eli Lilly (LLY) and NVIDIA (NVDA). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Eli Lilly (LLY) and NVIDIA (NVDA)
MetricLLYNVDA
Total Return (1Y)52.36%-5.54%
Total Return (3Y, Annualized)34.18%55.88%
Total Return (5Y, Annualized)41.08%42.17%

Risk Profile

Drawdown History

LLY
NVDA
GSPC
Loading price history…
Eli Lilly (LLY) vs. NVIDIA (NVDA), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Eli Lilly (LLY) and NVIDIA (NVDA). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

NVIDIA (NVDA) has a highly aggressive beta of 2.28, indicating much higher sensitivity to broad-market moves, while Eli Lilly (LLY) is defensive at 0.40 and tends to be less market-sensitive — a wide gap in beta profiles.

Risk profile metrics for Eli Lilly (LLY) and NVIDIA (NVDA)
MetricLLYNVDA
Volatility (1Y, Annualized)35.34%38.31%
Beta (5Y)0.402.28
Max Drawdown (5Y)-34.48%-66.34%
Avg. Volume (3M)2.52M120.20M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
LLY and NVDA are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Eli Lilly (LLY) and NVIDIA (NVDA)
MetricLLYNVDA
Sharpe Ratio (1Y)1.36-0.26
Sortino Ratio (1Y)2.29-0.36

Profitability

ROE (TTM)

Both companies show strong equity returns, but NVIDIA (NVDA) at 117.21% is the standout with ROE above its industry range; Eli Lilly (LLY) at 86.02% also sits in the top quartile.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

86.02%

Max
109.18%
LLY
86.02%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

NVDA

Semiconductors & Semiconductor Equipment industry group

117.21%

NVDA
117.21%
Max
52.82%
Q3
22.26%
Median
10.58%
Q1
1.29%
Min
-16.89%
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their ROE against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Net Margin (TTM)

Eli Lilly (LLY) at 31.90% keeps the most of each sales dollar — above its industry’s net margin range — and NVIDIA (NVDA) at 63.66% also retains a top-quartile share.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

31.90%

LLY
31.90%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

NVDA

Semiconductors & Semiconductor Equipment industry group

63.66%

Max
63.80%
NVDA
63.66%
Q3
28.36%
Median
11.44%
Q1
0.90%
Min
-37.77%
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Operating Margin (TTM)

NVIDIA (NVDA) at 66.24% shows unusually strong operating efficiency — above its industry’s operating margin range — and Eli Lilly (LLY) at 53.66% also operates in the top quartile.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

53.66%

Max
83.12%
LLY
53.66%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

NVDA

Semiconductors & Semiconductor Equipment industry group

66.24%

NVDA
66.24%
Max
58.66%
Q3
30.23%
Median
15.91%
Q1
7.54%
Min
-25.74%
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Profitability Metrics

Profitability metrics for Eli Lilly (LLY) and NVIDIA (NVDA)
MetricLLYNVDA
ROE (TTM)86.02%117.21%
ROA (TTM)21.06%53.57%
Net Margin (TTM)31.90%63.66%
Operating Margin (TTM)53.66%66.24%
Gross Margin (TTM)83.63%74.67%

Growth

Revenue Growth

NVIDIA (NVDA) at 65.47% clears its industry range for revenue growth, far stronger top-line momentum than Eli Lilly (LLY) at 44.70%, which is closer to a typical peer reading.

Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both Eli Lilly (LLY) at 95.99% and NVIDIA (NVDA) at 66.67% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.

Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Eli Lilly (LLY) and NVIDIA (NVDA)
MetricLLYNVDA
Revenue Growth (YoY)44.70%65.47%
Revenue Growth (3Y CAGR)31.69%100.05%
EPS Growth (YoY)95.99%66.67%
EPS Growth (3Y CAGR)51.71%204.24%

Financial Strength

Current Ratio (MRQ)

NVIDIA (NVDA) at 4.59 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.39 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.39

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
LLY
1.39
Min
0.10

NVDA

Semiconductors & Semiconductor Equipment industry group

4.59

Max
10.33
Q3
5.62
NVDA
4.59
Median
3.33
Q1
2.35
Min
1.03
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Debt / Equity (MRQ)

NVIDIA (NVDA) at 0.17 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.23 uses more debt funding than most peers.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.23

Max
1.42
LLY
1.23
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00

NVDA

Semiconductors & Semiconductor Equipment industry group

0.17

Max
1.46
Q3
0.65
Median
0.27
NVDA
0.17
Q1
0.04
Min
0.00
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their debt-to-equity ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Financial Strength Metrics

Financial strength metrics for Eli Lilly (LLY) and NVIDIA (NVDA)
MetricLLYNVDA
Current Ratio (MRQ)1.394.59
Debt / Equity (MRQ)1.230.17
Net Debt / EBITDA0.96-0.12

Dividends

Dividend Yield (TTM)

NVIDIA (NVDA) at 0.15% pays an industry-typical yield; Eli Lilly (LLY) at 0.49% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.49%

LLY
0.49%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

NVDA

Semiconductors & Semiconductor Equipment industry group

0.15%

Max
1.37%
Q3
0.65%
NVDA
0.15%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Dividend Payout Ratio (TTM)

NVIDIA (NVDA) at 3.54% keeps its payout in the industry’s typical band, while Eli Lilly (LLY) at 21.71% pays out more than any of its peers — the most stretched cover in its group.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.71%

LLY
21.71%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

NVDA

Semiconductors & Semiconductor Equipment industry group

3.54%

Max
49.64%
Q3
21.71%
NVDA
3.54%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Dividend Metrics

Dividend metrics for Eli Lilly (LLY) and NVIDIA (NVDA)
MetricLLYNVDA
Dividend Yield (TTM)0.49%0.15%
Dividend Payout Ratio (TTM)21.71%3.54%

Valuation

P/E Ratio (TTM)

NVIDIA (NVDA) at 23.60 sits in the cheaper P/E ratio quartile, while Eli Lilly (LLY) at 43.95 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

43.95

Max
85.34
LLY
43.95
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07

NVDA

Semiconductors & Semiconductor Equipment industry group

23.60

Max
110.34
Q3
66.81
Median
37.02
Q1
23.96
NVDA
23.60
Min
8.12
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

P/S Ratio (TTM)

Eli Lilly (LLY) at 13.95 is priced about in line with its industry on P/S ratio, while NVIDIA (NVDA) at 14.88 sits in the pricier quartile — NVDA costs more per dollar of sales.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.95

Max
58.18
Q3
25.77
LLY
13.95
Median
7.30
Q1
3.01
Min
0.01

NVDA

Semiconductors & Semiconductor Equipment industry group

14.88

Max
21.42
NVDA
14.88
Q3
12.27
Median
5.76
Q1
2.73
Min
0.00
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

P/B Ratio (MRQ)

Measured against book value, both Eli Lilly (LLY) at 29.96 and NVIDIA (NVDA) at 19.68 look expensive — each P/B ratio sits above its industry’s benchmark range.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

29.96

LLY
29.96
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

NVDA

Semiconductors & Semiconductor Equipment industry group

19.68

NVDA
19.68
Max
14.06
Q3
7.44
Median
4.29
Q1
2.30
Min
0.20
Loading chart…
Eli Lilly (LLY) vs. NVIDIA (NVDA): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Valuation Metrics

Valuation metrics for Eli Lilly (LLY) and NVIDIA (NVDA)
MetricLLYNVDA
P/E Ratio (TTM)43.9523.60
P/S Ratio (TTM)13.9514.88
P/B Ratio (MRQ)29.9619.68
Free Cash Flow Yield (TTM)0.77%0.93%